Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Atorvastatin effect on vascular inflammation measured by 68Ga-DOTATATE PET-CT in type 2 diabetes
NL-OMON20201Not yet recruiting
- Start
- Jun 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label trial of atorvastatin in type 2 diabetes mellitus (T2DM), sponsored by None. Primary endpoints: Change in arterial wall inflammation by 68Ga-DOTATATE PET-CT and Arterial wall inflammation including coronary arteries. Planned start Jun 2019; status: not yet recruiting.
02
Drugs
atorvastatin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NL-OMON20201.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON20201.